Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.7K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.0K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

80
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
80
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

943
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
943

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A near-infrared fluorescent probe with rapid-response hypochlorite for imaging rheumatoid arthritis and wound healing in vivo.

Talanta·2026
Same author

Activity-Based Multimodal Probes Uncover the AChE-ADGRB Axis in Cellular and Murine Models of Depression.

Analytical chemistry·2026
Same author

The effect of a nurse-led health education intervention on treatment delay in patients with diabetic high-risk foot: A randomised controlled trial.

International journal of nursing studies·2025
Same author

Synthesis of Psidium meroterpenoids with anti-hepatocellular carcinoma activities.

Bioorganic & medicinal chemistry·2025
Same author

Lysine-Targeting, Covalent Inhibitors of Bromodomain BD1 of BET Proteins in Live Cells and Animals.

Angewandte Chemie (International ed. in English)·2025
Same author

Chemical Probe-Enabled Lipid Droplet Proteomics.

Journal of the American Chemical Society·2025

Related Experiment Video

Updated: Oct 26, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.6K

Natural STAT3 inhibitors: A mini perspective.

Zhuo Wang1, Chunngai Hui2, Yusheng Xie3

  • 1Southern University of Science and Technology, School of Medicine, Shenzhen 518055, People's Republic of China.

Bioorganic Chemistry
|August 1, 2021
PubMed
Summary
This summary is machine-generated.

Natural products offer promising therapeutic strategies by inhibiting Signal transducer and activator of transcription 3 (STAT3), a key oncogene in cancer. This review details natural STAT3 inhibitors, their biological profiles, and synthesis, highlighting their potential.

Keywords:
InhibitorsJAKNatural productsSTAT3Synthesis

Related Experiment Videos

Last Updated: Oct 26, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is crucial for cell proliferation and survival, with aberrant activation linked to numerous cancers.
  • STAT3 is recognized as a significant oncogene and a critical target for cancer therapy.
  • While small molecule STAT3 inhibitors are extensively studied, natural product inhibitors remain less explored.

Purpose of the Study:

  • To review the development of natural product-derived STAT3 inhibitors.
  • To detail their biological activities and chemical synthesis.
  • To discuss the current landscape and future prospects of STAT3 inhibitor research.

Main Methods:

  • Literature review focusing on natural products targeting the STAT3 pathway.
  • Analysis of biological profiles and chemical synthesis of identified natural STAT3 inhibitors.
  • Discussion of existing STAT3 inhibitors and future research directions.

Main Results:

  • Numerous natural products have been identified as STAT3 inhibitors.
  • These natural compounds exhibit diverse biological activities relevant to cancer therapy.
  • The chemical synthesis and biological profiles of these natural inhibitors are detailed.

Conclusions:

  • Natural products represent a valuable and underexplored source of STAT3 inhibitors.
  • Further research into natural STAT3 inhibitors could lead to novel cancer therapeutics.
  • Exploring the synthesis and biological mechanisms of these compounds offers significant opportunities.